FDA OKs Bristol's HIV drug for younger patients

Bristol-Myers Squibb Co. said Friday that U.S. regulators expanded approval of its HIV drug Sustiva to children as young as three months old.

http://www.rdmag.com/news/2013/05/fda-oks-bristols-hiv-drug-younger-patients